| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.51B | — | +4.7% |
| Cost of Revenue | $930.2M | — | -19.2% |
| Gross Profit | $583.1M | — | +98.5% |
| R&D Expense | $144.3M | — | -12.1% |
| SG&A Expense | $89.4M | — | +5.9% |
| Operating Income | -$53.4M | — | +90.7% |
| Income Tax | -$11.7M | — | +84.6% |
| Net Income | -$33.4M | — | +93.1% |
| EPS (Basic) | -$0.08 | — | +93.0% |
| EPS (Diluted) | -$0.08 | — | +93.0% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.00B | -6.7% | -27.5% |
| Short-term Investments | $400.0M | +0.0% | +60.0% |
| Accounts Receivable | $862.8M | -5.0% | +4.6% |
| Inventory | $2.05B | +3.0% | -1.4% |
| Current Assets | $5.78B | -0.8% | -8.7% |
| Total Assets | $12.01B |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $239.1M | — | -60.3% |
| Capital Expenditures | $21.9M | — | -85.2% |
| Investing Cash Flow | -$16.7M | — | +92.2% |
| Financing Cash Flow | -$366.0M | — | -15.2% |
| Free Cash Flow | $217.2M | — | -52.2% |
| -9.4% |
| Current Liabilities | $1.19B | -8.0% | -7.3% |
| Long-term Debt | $3.00B | +0.8% | -11.1% |
| Total Liabilities | $4.69B | -2.9% | -9.9% |
| Stockholders' Equity | $7.30B | -4.8% | -9.1% |